Use of a selective estrogen receptor modulator for the manufacture of a pharmaceutical preparation for use in a method for the treatment or prevention of androgen deficiency

Details for Australian Patent Application No. 2005279178 (hide)

Owner Hormos Medical Ltd.

Inventors Komi, Janne; Blom, Taru; Lammintausta, Risto

Agent Watermark

Pub. Number AU-A-2005279178

PCT Pub. Number WO2006/024689

Priority 60/606,907 03.09.04 US; 20041216 21.09.04 FI

Filing date 20 July 2005

Wipo publication date 9 March 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/085 (2006.01)

A61K 31/10 (2006.01)

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/024689 Priority application(s): WO2006/024689

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005279193-Shading process

2005279163-Fermented milk or vegetable proteins comprising receptor ligand and uses thereof